Midatech Pharma (Nasdaq:MTP) announced today that it extended its R&D collaboration with Johnson & Johnson’s (NYSE:JNJ) Janssen Pharmaceuticals.
Cardiff, United Kingdom-based Midatech, a drug delivery technology company focused on the biodelivery and biodistribution of medicines, initially entered into the R&D collaboration with Janssen on July 21, 2020.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: Drug Delivery, Drug Discovery, Drug Discovery and Development, RD
Tell Us What You Think!
You must be logged in to post a comment.